INVESTORS
Investment Benefits
Investing in HMP offers a revenue opportunity in the rapidly growing Artificial Intelligence sector in the healthcare market size (CAGR of 37.1% from 2024 to 2032, with a global market value projected at $317.1 billion).
An innovative pay-per-use business model will facilitate the expected expansion in the sports, rehabilitation and chronic disease prevention and treatment markets.
Med-Tech Market Growth
HMP is at the forefront of the development of preventive solutions for Musculoskeletal Disorders (MSDs), offering tangible benefits for patients and healthcare systems. The BMPOD (Brain Motor Patterns Optimizer Device) combines IoT technology and Machine Learning algorithms to identify pathological motor patterns and suggest optimal postural alignment.
This innovation allows to reduce the need for surgical interventions and invasive treatments, with a positive impact on the quality of life of patients and on the costs for healthcare systems.
Furthermore, the international patent of BMPOD guarantees intellectual property protection and an exclusive positioning on the market. Investments in HMP will not only support the further technological development of the device, but also its certification and clinical validation, strengthening the credibility and reliability of the proposed solution.
With HMP, investors participate in a project that not only generates profit, but redefines the state of the art in the prevention and management of MSDs.
